Guselkumab (Tremfya): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
7
Conditions studied
0
US states with sites
2
Countries
Phase breakdown
Not applicable 2
Conditions being studied
| Condition | Trials |
|---|---|
| Crohn Disease (CD) | 1 |
| Crohn's disease | 1 |
| IBD-unclassified (IBD-U) | 1 |
| Inflammatory Bowel Disease (IBD) | 1 |
| Psoriasis | 1 |
| Ulcerative Colitis (UC) | 1 |
| Ulcerative colitis | 1 |
Recruiting trials involving Guselkumab (Tremfya)
- Real-Life Evaluation of Guselkumab Dosing Interval Adjustments
- Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Common questions
How many recruiting trials involve Guselkumab (Tremfya)?
2 recruiting trials across 7 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.